IEQ Capital’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.22M | Buy |
537,362
+252,064
| +88% | +$2.92M | 0.04% | 365 |
|
2025
Q1 | $2.49M | Buy |
285,298
+127,186
| +80% | +$1.11M | 0.02% | 527 |
|
2024
Q4 | $2.27M | Buy |
158,112
+50,722
| +47% | +$728K | 0.02% | 468 |
|
2024
Q3 | $2.42M | Buy |
107,390
+3,432
| +3% | +$77.5K | 0.03% | 335 |
|
2024
Q2 | $2.02M | Sell |
103,958
-27,283
| -21% | -$531K | 0.03% | 339 |
|
2024
Q1 | $4.93M | Buy |
131,241
+3,117
| +2% | +$117K | 0.07% | 182 |
|
2023
Q4 | $7.17M | Buy |
128,124
+165
| +0.1% | +$9.23K | 0.12% | 120 |
|
2023
Q3 | $5.28M | Sell |
127,959
-892
| -0.7% | -$36.8K | 0.11% | 128 |
|
2023
Q2 | $7.2M | Buy |
128,851
+304
| +0.2% | +$17K | 0.15% | 107 |
|
2023
Q1 | $7.17M | Buy |
128,547
+2
| +0% | +$112 | 0.17% | 97 |
|
2022
Q4 | $4.68M | Buy |
128,545
+23,813
| +23% | +$868K | 0.13% | 135 |
|
2022
Q3 | $2.98M | Buy |
104,732
+34,575
| +49% | +$985K | 0.08% | 171 |
|
2022
Q2 | $3.18M | Buy |
70,157
+1,499
| +2% | +$67.8K | 0.1% | 143 |
|
2022
Q1 | $5.22M | Buy |
68,658
+22,036
| +47% | +$1.68M | 0.12% | 106 |
|
2021
Q4 | $6.95M | Buy |
46,622
+10,930
| +31% | +$1.63M | 0.16% | 81 |
|
2021
Q3 | $5.2M | Buy |
35,692
+725
| +2% | +$106K | 0.14% | 96 |
|
2021
Q2 | $6.85M | Buy |
34,967
+30,620
| +704% | +$6M | 0.2% | 71 |
|
2021
Q1 | $787K | Buy |
+4,347
| New | +$787K | 0.03% | 233 |
|
2020
Q4 | – | Sell |
-2,304
| Closed | -$287K | – | 378 |
|
2020
Q3 | $287K | Buy |
+2,304
| New | +$287K | 0.02% | 309 |
|